Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- AMGEN INC
- Publication Date
- 2001-12-05
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] This application claims priority to US Provisional Application 06 / 105,348, filed October 23, 1998. field of invention
[0002] Basically, the present invention relates to the field of compounds, in particular peptides or polypeptides having thrombopoietic activity. The peptides or polypeptides of the present invention can be used in mammals to increase the production of platelets or platelet precursors such as megakaryocytes. Background of the invention
[0003] The present invention relates to the field of compounds, particularly peptides having the ability to stimulate the production of platelets and their precursors, such as megakaryocytes, in vitro and in vivo. Before discussing the properties of the compounds of the present invention, two proteins with thrombopoietic activity: thrombopoietin (TPO) and megakaryocyte growth and development factor (MGDF) are provided as background information below.
[0004] Cloning o...